Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Handel

Showing results (61-70 of 102) with videos related to

Pageof 11
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|November 3, 2010
Influenza epitope-specific CD8+ T cell avidity, but not cytokine polyfunctionality, can be determined by TCRβ clonotypeJessica M Moffat, Andreas Handel, Peter C Doherty, et al.
Epidemics|November 9, 2016
Targeting pediatric versus elderly populations for norovirus vaccines: a model-based analysis of mass vaccination optionsMolly K Steele, Justin V Remais, Manoj Gambhir, et al.
Medrxiv : the Preprint Server for Health Sciences|August 21, 2020
Considering indirect benefits is critical when evaluating SARS-CoV-2 vaccine candidatesMolly E Gallagher, Andrew J Sieben, Kristin N Nelson, et al.
Scientific Reports|March 16, 2021
A modeling study to inform screening and testing interventions for the control of SARS-CoV-2 on university campusesBen Lopman, Carol Y Liu, Adrien Le Guillou, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 30, 2014
Reproducible selection of high avidity CD8+ T-cell clones following secondary acute virus infectionTania Cukalac, Jesseka Chadderton, Andreas Handel, et al.
Emerging Infectious Diseases|July 21, 2020
Characterizing Norovirus Transmission from Outbreak Data, United StatesMolly K Steele, Mary E Wikswo, Aron J Hall, et al.
The Journal of Infectious Diseases|June 27, 2025
Evaluating the Breadth and Reliability of Influenza Vaccine Protection Indicators: a Secondary Analysis of an Animal Challenge TrialYao Lu, James D Allen, Ted M Ross, et al.
The Journal of Infectious Diseases|August 25, 2023
Assessment of Humoral Immune Responses to Repeated Influenza Vaccination in a Multiyear Cohort: A 5-Year Follow-upMeng-Hsuan Sung, W Zane Billings, Michael A Carlock, et al.
Vaccine|July 30, 2024
Pre-existing immunity to influenza aids ferrets in developing stronger and broader H3 vaccine-induced antibody responsesYang Ge, Yao Lu, James D Allen, et al.
BMC Infectious Diseases|August 22, 2015
Four Degrees of Separation: Social Contacts and Health Providers Influence the Steps to Final Diagnosis of Active Tuberculosis Patients in Urban UgandaJuliet N Sekandi, Sarah Zalwango, Leonardo Martinez, et al.
Pageof 11

Showing results (61-70 of 102) with videos related to

Sort By:
Pageof 11
Journal of Immunology (Baltimore, Md. : 1950)|November 3, 2010
Influenza epitope-specific CD8+ T cell avidity, but not cytokine polyfunctionality, can be determined by TCRβ clonotypeJessica M Moffat, Andreas Handel, Peter C Doherty, et al.
Epidemics|November 9, 2016
Targeting pediatric versus elderly populations for norovirus vaccines: a model-based analysis of mass vaccination optionsMolly K Steele, Justin V Remais, Manoj Gambhir, et al.
Medrxiv : the Preprint Server for Health Sciences|August 21, 2020
Considering indirect benefits is critical when evaluating SARS-CoV-2 vaccine candidatesMolly E Gallagher, Andrew J Sieben, Kristin N Nelson, et al.
Scientific Reports|March 16, 2021
A modeling study to inform screening and testing interventions for the control of SARS-CoV-2 on university campusesBen Lopman, Carol Y Liu, Adrien Le Guillou, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 30, 2014
Reproducible selection of high avidity CD8+ T-cell clones following secondary acute virus infectionTania Cukalac, Jesseka Chadderton, Andreas Handel, et al.
Emerging Infectious Diseases|July 21, 2020
Characterizing Norovirus Transmission from Outbreak Data, United StatesMolly K Steele, Mary E Wikswo, Aron J Hall, et al.
The Journal of Infectious Diseases|June 27, 2025
Evaluating the Breadth and Reliability of Influenza Vaccine Protection Indicators: a Secondary Analysis of an Animal Challenge TrialYao Lu, James D Allen, Ted M Ross, et al.
The Journal of Infectious Diseases|August 25, 2023
Assessment of Humoral Immune Responses to Repeated Influenza Vaccination in a Multiyear Cohort: A 5-Year Follow-upMeng-Hsuan Sung, W Zane Billings, Michael A Carlock, et al.
Vaccine|July 30, 2024
Pre-existing immunity to influenza aids ferrets in developing stronger and broader H3 vaccine-induced antibody responsesYang Ge, Yao Lu, James D Allen, et al.
BMC Infectious Diseases|August 22, 2015
Four Degrees of Separation: Social Contacts and Health Providers Influence the Steps to Final Diagnosis of Active Tuberculosis Patients in Urban UgandaJuliet N Sekandi, Sarah Zalwango, Leonardo Martinez, et al.
Pageof 11